Does shareholder value make sense in healthcare organisations in order to assess investment proposals?
by Giovanni Azzone, Emanuele Lettieri, Cristina Masella
International Journal of Healthcare Technology and Management (IJHTM), Vol. 4, No. 3/4, 2002

Abstract: The Italian healthcare system is today involved in a significant renewal process, aimed at improving effectiveness, efficiency and monitoring costs. Increasing competition and continuous reduction in public expenditure for the healthcare sector call for a management able to allocate the available resources (human, financial and technological) to the more promising projects, avoiding the waste of resources in unsustainable or useless investment proposals. The aim of this paper is to present a formal method to evaluate investments in medical technology, based on shareholder value theory. The method has been tested at the Department of Oncology at an Italian healthcare organisation in order to assess the benefits and costs due to the introduction of a new generation linear accelerator.

Online publication date: Tue, 01-Jul-2003

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Healthcare Technology and Management (IJHTM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com